LON:SENS Sensyne Health (SENS) Share Price, News & Analysis GBX 0.35 -0.18 (-33.33%) (As of 06/17/2022) Add Compare Share Share Stock Analysis Stock Analysis About Sensyne Health Stock (LON:SENS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Sensyne Health alerts:Sign Up Key Stats Today's Range 0.16▼ 0.6050-Day Range 0.35▼ 0.3552-Week Range 0.16▼ 155Volume4.45 million shsAverage Volume3.45 million shsMarket Capitalization£582,624.00P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care’s ‘Initial Code of Conduct for data-driven health and care technology’.Read More… Next Week Elon Could Trigger a Boom in this Sub-$3 Stock (Ad)Next week, you’ll have a chance to get in on the ground floor of what could be Elon’s next big thing. You see, he’s set to reveal his new AI product that I believe will shock the world… Click here to see the details and save your seat. Receive SENS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sensyne Health and its competitors with MarketBeat's FREE daily newsletter. Email Address SENS Stock News HeadlinesLeading Artificial Intelligence (AI) Companies in Clinical TrialsSeptember 24, 2024 | finance.yahoo.comBig Pharma is forging an increased number of partnerships with artificial intelligence vendors for drug discovery servicesJuly 22, 2024 | finance.yahoo.comGet Ready for Next Week’s Elon Musk Shock I believe Elon Musk is about to shock the world again next week… When he’s set to unveil his new AI product. I’m hosting a special online strategy session to help you prepare on Monday at 10am ET.October 2, 2024 | InvestorPlace (Ad)Best Collagen Powders Of 2024, According To ExpertsMarch 9, 2024 | forbes.comNHS data sale 'an invasion of privacy', campaigners sayDecember 8, 2023 | bbc.comAre Health Insurance Premiums Tax-Deductible?August 3, 2023 | investopedia.comBMI Calculator: Check Your Body Mass IndexJune 8, 2023 | forbes.comFind The Right Health Insurance For YouMay 27, 2023 | forbes.comSee More Headlines SENS Stock Analysis - Frequently Asked Questions How have SENS shares performed this year? Sensyne Health's stock was trading at GBX 0.35 at the beginning of the year. Since then, SENS stock has increased by 0.0% and is now trading at GBX 0.35. View the best growth stocks for 2024 here. How do I buy shares of Sensyne Health? Shares of SENS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Sensyne Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sensyne Health investors own include Fresenius Medical Care (FME), Green Plains Partners (GPP), Hershey (HSY), Gilead Sciences (GILD), Griffon (GFF), Emerald (EEX) and DHX Media (DHXM). Industry, Sector and Symbol Stock ExchangeLON SectorComputer and Technology Industry Health Information Services Sub-IndustryN/A Current SymbolLON:SENS CUSIPN/A CIKN/A Webwww.sensynehealth.com Phone44 3300 581845FaxN/AEmployees70Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio5.83 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio6.02 Current Ratio2.26 Quick Ratio2.26 Sales & Book Value Annual Sales£7.81 million Price / Sales0.07 Cash FlowGBX 4.90 per share Price / Cash Flow0.07 Book ValueGBX 20.30 per share Price / Book0.02Miscellaneous Outstanding Shares166,464,000Free FloatN/AMarket Cap£582,624.00 OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (LON:SENS) was last updated on 10/2/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredThey laughed when he picked Nvidia in 2016…Everyone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredFor Elon, I fear the worst is yet to come…Early last year I predicted that there would be a war on Elon Musk. This hateful rhetoric has led to two s...Porter & Company | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensyne Health PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensyne Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.